
Targeted in vivo expression of the cyclin-dependent kinase inhibitor p21 halts hepatocyte cell-cycle progression, postnatal liver development and regeneration.
Author(s) -
H. Wu,
Michael S. Wade,
Leonard Krall,
Joe W. Grisham,
Yue Xiong,
Terry Van Dyke
Publication year - 1996
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/ksh8-a655
Subject(s) - liver regeneration , hepatocyte , in vivo , microbiology and biotechnology , regeneration (biology) , kinase , cell cycle , cyclin e1 , cyclin dependent kinase , cancer research , cyclin , biology , chemistry , cyclin dependent kinase 2 , cell , in vitro , protein kinase a , biochemistry , genetics